Director Milton C. Ault, III Makes Significant Open Market Purchase of ALZN Shares

summarizeSummary

Director Milton C. Ault, III purchased $108,897 worth of Alzamend Neuro common stock in an open market transaction, representing a significant investment relative to the company's market capitalization.

check_boxKey Events

• Director's Substantial Share Purchase

  Milton C. Ault, III, a Director of Alzamend Neuro, Inc., acquired 108,388 shares of common stock for a total of $108,897.42 in an open market transaction on April 14, 2026.

• Significant Investment Relative to Market Cap

  This purchase represents approximately 2.86% of the company's current market capitalization, indicating a strong vote of confidence from a key insider.

• Indirect Ownership

  The shares were acquired indirectly through Ault Lending, LLC, a wholly-owned subsidiary of Hyperscale Data, Inc., where Mr. Ault serves as Executive Chairman.

auto_awesomeAnalysis

This Form 4 filing indicates a substantial open market purchase by Director Milton C. Ault, III. The acquisition of over $108,000 in shares, representing approximately 2.86% of the company's market capitalization, signals strong conviction from a key insider. Such a significant investment, especially for a company of Alzamend Neuro's size, can be interpreted as a positive vote of confidence in the company's future prospects. Investors may view this as a bullish indicator, particularly given the company's recent capital raising activities, suggesting that a director is willing to personally invest alongside the company's financing efforts.